- This event has passed.
“Profiling Cells Inside and Out Using Nanostructured Materials” featuring Dr. Shana Kelley
May 10, 2018 @ 11:00 am - 12:00 pm
Profiling Cells Inside and Out Using Nanostructured Materials
Dr. Shana Kelley
University of Toronto
Thursday, May 10, 2018
11:00 AM – 12:00 PM
Natural Sciences I, Room 1114
Nanostructured materials possess a variety of properties that can enhance the speed and sensitivity of biomolecular and cellular detection. The length scale of many nanomaterials enhances their ability to contact individual molecules, and their surface-to-volume ratios can produce enhanced levels of signal. The magnetic, electrochemical and optical properties of nanomaterials are also highly sensitive to small changes in local environment, which also enhances the performance of nanostructured detectors. We have developed a variety of new solutions for biomolecular and cellular analysis powered by inorganic nanomaterials. Three-dimensional, nanostructured sensors for electrochemical analysis of biomolecular targets have been engineered using electrodeposited metals and shown to exhibit clinically-relevant levels of sensitivity and specificity. As well, a nanoparticle-mediated approach to the analysis and phenotypic profiling of circulating tumor cells allows these rare cells to be analyzed in patient samples for cancer monitoring. These new tools enhance the level of information that can be collected from clinical specimens, and provide new possibilities for molecular analysis in medicine.
About Dr. Shana Kelley
Dr. Shana Kelley is a Distinguished Professor of Pharmaceutical Sciences, Chemistry, Biochemistry, and Biomedical Engineering at the University of Toronto. Dr. Kelley received her Ph.D. from the California Institute of Technology and was a NIH postdoctoral fellow at the Scripps Research Institute. The Kelley research group works in a variety of areas spanning bioanalytical chemistry, chemical biology and nanotechnology.
Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, the 2011 Steacie Prize, and the 2016 NSERC Brockhouse Prize. She has also been recognized with the ACS Inorganic Nanoscience Award, Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review. She is a founder of two molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005) and Xagenic Inc. (acquired by General Atomics in 2017), and sits on the Board of Directors of the Ontario Genomics Institute and the Fight Against Cancer Trust.